Starpharm - A turnaround pharma stock

Jiayou....

Listed Pharma China Companies in cancer treatment drugs are being chased hard now. starpharm has two cancer treatment drugs and maybe they are the reasons for recent run up.

---

抗癌概念股获得热钱追捧 2013年07月01日 14:18　来源：滨海时报　参与互动(0)0　　

　　近日，抗癌概念股走势相对强劲。业内人士认为这是事件驱动型的又一典范之作，因为欧盟第七框架研发计划资助的一项由多个成员国科学家组成研究课题，在抗癌药物靶向输送上取得了重要进展，这或可带来癌症治疗上的新突破。该项目以环糊精(Cyclondextrins)为基础，致力于开发新型的糖基抗癌药物输送系统，提高抗癌药物的效力。这意味着抗癌概念股具备了新的炒作题材，受此影响，热钱开始关注其间的受益品种。更为重要的是，抗癌概念股在近一年来一直是A股热钱追捧的对象，因为抗癌药大多是首仿药或原研药，在药品定价体系中，尤其是招标过程中，享受更高的产品定价，因此，对药价的下降趋势并不敏感，从而保证上了癌症药生产厂商的盈利能力。另外，抗癌药的研发体系也渐趋完善，因此，有利于提升治疗癌症药物研发进程。

　　建议投资者关注两类个股，一是短线抗跌品种，意味着短线热钱拉升意愿强烈，如安琪酵母、江苏吴中、海欣股份、安科生物等；二是在单抗等首仿药以及拥有重磅产品的抗癌药概念股也可跟踪，如丽珠集团、海南海药、恒瑞医药、智飞生物等。综合

chinsoonyuen wrote: gangho, how much did you load up lately?

Chin,

I didn't add much lately.

It seems like consolidating at ard 10-11c. There are no many sellers probably due to not many retailers managed to buy due to the super quick run up. I suspect most of the shares were bought by the big boys.

Let's see what happens over the next few days.

it had already run up so much for the past few says, it good to allow the stock to correct a little for the next pump up.

Must stop and breath a bit after the quick run up last week and yesterday.

Lets just wait for the next buy up

Rank Bid Volume Bid Price Ask Price Ask Volume
1 8,000 0.101 0.104 60,000
2 150,000 0.100 0.105 200,000
3 188,000 0.097 0.106 70,000
4 300,000 0.096 0.108 45,000
5 250,000 0.095 0.109 190,000
6 160,000 0.092 0.110 198,000
7 110,000 0.090 0.112 100,000
8 50,000 0.084 0.113 90,000
9 60,000 0.063 0.115 140,000
10 30,000 0.060 0.118 162,000
11 100,000 0.052 0.120 88,000
12 0 0.000 0.122 100,000
13 0 0.000 0.124 260,000
14 0 0.000 0.129 70,000
15 0 0.000 0.000 0
16 0 0.000 0.000 0
17 0 0.000 0.000 0
18 0 0.000 0.000 0
19 0 0.000 0.000 0
20 0 0.000 0.000 0